$FRPT

Cyr William B. sold $3.0M of FRPT

Cyr William B. (Chief Executive Officer) sold 41,023 shares of Freshpet, Inc. (FRPT) at $72.91 ($2.99M total) on 2026-08-14 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Cyr William B.
Published Aug 18, 2026, 8:06 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 18, 2026, 8:32 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$FRPT
Neutral
medium confidence
Mentioned
$FRPT
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$FRPTNeutralLow
01

Why it matters

The newest fact is the CEO’s open-market sale details (shares, price, total value) and that it was executed under a pre-arranged 10b5-1 plan.

02

Market read

This provides a fresh, timestamped insider-sale datapoint, but it does not introduce new fundamentals or guidance.

03

What to watch

Traders may overreact to insider selling; the key differentiator here is the explicit 10b5-1 pre-arrangement, which typically lowers interpretive weight.

Relevance 5/10Novelty 3/10Timing: SEC Form 4 filed after-hours on 2026-08-18

Background

The article is an SEC Form 4 insider transaction disclosure for Freshpet, Inc. (FRPT).

Company-level read

Ticker impact

$FRPTNeutralMedium confidence
Context

Freshpet CEO Cyr William sold 41,023 shares in an open-market transaction for about $2.99M under a pre-arranged 10b5-1 plan.

Expected impact

Likely limited near-term impact; any reaction would be sentiment-driven rather than a new fundamental catalyst.

Evidence & confidence

The filing provides transaction size, price, and 10b5-1 status, but no new company-specific operating or financial information.

Market effects

Minimal, as this is a single-company insider sale without sector-wide regulatory or earnings implications.

None indicated.

None indicated.

Counterpoint

Because the sale is under a pre-arranged 10b5-1 plan, it may reflect routine liquidity needs rather than bearish expectations.

Key entities

  • Freshpet, Inc.

    Company whose CEO executed an open-market sale disclosed on Form 4.

  • Cyr William B.

    Freshpet CEO and director who sold shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$FRPTHighAI 9/10

Freshpet (FRPT) Q2 2026 Earnings Call Transcript

Freshpet (FRPT) reported Q2 2026 results ahead of its guidance range, with its strongest growth rate in over a year and highest adjusted gross margin since Q1 2020. The company raised 2026 sales and adjusted EBITDA guidance. It cited 41% digital order growth to 16.7% of sales, and expects 700 rural lifestyle retail stores by year-end.

$FRPTMed

Freshpet (FRPT) Is Up 12.4% After Raising 2026 Sales Outlook And Margins Improving - Has The Bull Case Changed?

Freshpet (FRPT) shares rose 12.4% after the company reported Q2 sales of $305.59 million and net income of $19.49 million, with improved year-to-date profitability and EPS. Freshpet said a shift toward loyal “MVP” households and higher adjusted gross margin supported lifting 2026 sales growth guidance to 10% to 12%, and it completed an $86.5 million share repurchase.

$FRPTHighAI 9/10

Freshpet CEO says company delivered its strongest growth rate in more than a year, as company announces 2nd quarter results

Freshpet reported Q2 2026 net sales up 15.5% to $305.6 million and gross profit of $128.7 million, 42.1% of sales. Net income rose to $19.5 million. CEO Billy Cyr cited stronger growth and highest adjusted gross margin since Q1 2020. The company updated 2026 guidance to 10% to 12% net sales growth and $210 million to $220 million adjusted EBITDA.

$FRPTHighAI 9/10

Why Are Freshpet (FRPT) Shares Soaring Today

Freshpet (FRPT) shares rose 12.7% after the company reported strong Q2 2026 results. Net sales were $305.6 million, up 15.5% year over year and above the $292.3 million consensus. EPS was $0.39 versus $0.22 expected. Adjusted EBITDA and a full-year adjusted EBITDA forecast midpoint of $215 million also beat estimates.

$FRPTMed

Freshpet Q2 Earnings Call Highlights

Freshpet (FRPT) said its low-end sales outlook assumes stable macro conditions, while hitting the high end would require stronger advertising, omnichannel gains, more distribution, faster category growth, and a return of trade-up. Q2 adjusted gross margin rose 170 bps to 48.6%. 2026 adjusted gross margin improvement guidance increased to 100 to 150 bps at the midpoint. Operating cash flow rose 31% to $44.4M; free cash flow was $14.7M.

$FRPTMedAI 8/10

Freshpet’s (NASDAQ:FRPT) Q2 CY2026: Strong Sales, Stock Soars

Freshpet (NASDAQ:FRPT) reported Q2 CY2026 results. Revenue rose 15.5% year on year to $305.6 million, exceeding Wall Street estimates by 4.5%, and GAAP profit was $0.39 per share, 73.6% above consensus. The article also cites analyst expectations for 7.1% revenue growth over the next 12 months and notes the stock rose 7.6% to $67.10 after the report.